These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35543375)

  • 1. Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5).
    Li Y; Yang X; Lu D
    Bioengineered; 2022 May; 13(5):11867-11880. PubMed ID: 35543375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXA1/UBE2T Inhibits CD8
    Pu J; Zhang D; Wang B; Zhu P; Yang W; Wang K; Yang Z; Song Q
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):134. PubMed ID: 38682180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2T promotes stage I lung adenocarcinoma progression through PBX1 ubiquitination and PBX1/RORA regulation.
    Deng Y; Chen X; Chen X; Huang C; Zhang Z; Xu Z; Wang X; Wu J; Li L; Song J; Zhou R
    BMC Cancer; 2024 Sep; 24(1):1158. PubMed ID: 39289660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UBE2T mediates SORBS3 ubiquitination to enhance IL-6/STAT3 signaling and promote lung adenocarcinoma progression.
    Pu J; Wang B; Zhang D; Wang K; Yang Z; Zhu P; Song Q
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23743. PubMed ID: 38816989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
    Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
    Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-543 impairs breast cancer cell phenotypes by targeting and suppressing ubiquitin-conjugating enzyme E2T (UBE2T).
    Li L; Li Q
    Bioengineered; 2021 Dec; 12(2):12394-12406. PubMed ID: 34787051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma.
    He Z; Zhang H; Xiao H; Zhang X; Xu H; Sun R; Li S
    J Transl Med; 2024 Feb; 22(1):216. PubMed ID: 38424632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-conjugating enzyme E2T(UBE2T) promotes colorectal cancer progression by facilitating ubiquitination and degradation of p53.
    Wu M; Li X; Huang W; Chen Y; Wang B; Liu X
    Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101493. PubMed ID: 32736946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBE2T promotes proliferation, invasion and glycolysis of breast cancer cells by regualting the PI3K/AKT signaling pathway.
    Qiao L; Dong C; Ma B
    J Recept Signal Transduct Res; 2022 Apr; 42(2):151-159. PubMed ID: 33435787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT.
    Zhang J; Wang J; Wu J; Huang J; Lin Z; Lin X
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma.
    Zhu J; Ao H; Liu M; Cao K; Ma J
    J Transl Med; 2021 Aug; 19(1):374. PubMed ID: 34461934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.
    Wu ZH; Zhang YJ; Sun HY
    Medicine (Baltimore); 2020 Jan; 99(4):e18543. PubMed ID: 31977847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of ERO1L attenuates tumor growth, migration and invasion in lung adenocarcinoma through Wnt/β‑catenin pathway.
    Zhang S; Zhang M; Ma W; Wang L; Yu B
    Biotechnol Genet Eng Rev; 2024 Nov; 40(3):1910-1923. PubMed ID: 37014092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation.
    Yin H; Wang X; Zhang X; Zeng Y; Xu Q; Wang W; Zhou F; Zhou Y
    Cancer Lett; 2020 Dec; 494():121-131. PubMed ID: 32590022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of microsomal glutathione S-transferase 1 inhibits lung adenocarcinoma cell proliferation and induces apoptosis.
    Zeng B; Ge C; Li R; Zhang Z; Fu Q; Li Z; Lin Z; Liu L; Xue Y; Xu Y; He J; Guo H; Li C; Huang W; Song X; Huang Y
    Biomed Pharmacother; 2020 Jan; 121():109562. PubMed ID: 31707341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
    Sui MH; Zhang WW; Geng DM; Sun DJ
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.